Page 191 - Read Online

Page 10 of 11 Hirschberg et al. Neuroimmunol Neuroinflammation 2018;5:27 I http://dx.doi.org/10.20517/2347-8659.2018.31

bleomycin for glioma treatment. Biomed Opt 2012;17:058001.
33. Shin D, Christie C, Ju D, Nair RK, Molina S, Berg K, Krasieva TB, Madsen SJ, Hirschberg H. Photochemical internalization enhanced
macrophage delivered chemotherapy. Photodiagnosis Photodyn Ther 2018;21:156-62.
34. Norum OJ, Fremstedal ASV, Weyergang A, Golab J, Berg K. Photochemical delivery of bleomycin induces T-cell activation of
importance for curative effect and systemic anti-tumor immunity. J Control Release 2017;268:120-7.
35. Haug M, Brede G, Håkerud M, Nedberg AG, Gederaas OA, Flo TH, Edwards VT, Selbo PK, Høgset A, Halaas Ø. Photochemical
internalization of peptide antigens provides a novel strategy to realize therapeutic cancer vaccination. Front Immunol 2018;9:650.
36. Hirschberg H, Madsen S, Lote K, Pham T, Tromberg B. An indwelling brachytherapy balloon catheter: potential use as an intracranial
light applicator for photodynamic therapy. J Neurooncol 1999;44:15-21.
37. Madsen SJ, Sun CH, Tromberg BJ, Hirschberg H. Development of a novel indwelling balloon applicator for optimizing light delivery in
photodynamic therapy. Lasers Surg Med 2001;29:406-12.
38. Johannesen TB, Norum J, Lote K, Scheie D, Hirschberg H. A cost-minimizing analysis of standard radiotherapy and two experimental
therapies in glioblastoma. Radiother Oncol 2002;62:227-31.
39. Eljamel MS, Goodman C, Moseley H. ALA and Photofrin fluorescence-guided resection and repetitive PDT in glioblastoma multiforme:
a single centre phase III randomised controlled trial. Lasers Med Sci 2008;23:361-7.
40. Muller PJ, Wilson BC. Photodynamic therapy of brain tumors—a work in progress. Lasers Surg Med 2006;38:384-9.
41. Muragaki Y, Akimoto J, Maruyama T, Iseki H, Ikuta S, Nitta M, Maebayashi K, Saito T, Okada Y, Kaneko S, Matsumura A, Kuroiwa
T, Karasawa K, Nakazato Y, Kayama T. Phase II clinical study on intraoperative photodynamic therapy with talaporfin sodium and
semiconductor laser in patients with malignant brain tumors. J Neurosurg 2013;119:845-52.
42. Bechet D, Mordon SR, Guillemin F, Barberi-Heyob MA. Photodynamic therapy of malignant brain tumors: a complementary approach
to conventional therapies. Cancer Treat Rev 2014;40:229-41.
43. Quirk BJ, Brandal G, Donlon S, Vera JC, Mang TS, Foy AB, Lew SM, Girotti AW, Jogal S, LaViolette PS, Connelly JM, Whelan HT.
Photodynamic therapy (PDT) for malignant brain tumors - where do we stand? Photodiagnosis Photodyn Ther 2015;12:530-44.
44. Li F, Cheng Y, Lu J, Hu R, Wan Q, Feng H. Photodynamic therapy boosts anti-glioma immunity in mice: a dependence on the activities
of T cells and complement C3. J Cell Biochem 2011;112:3035-43.
45. Olzowy B, Hundt CS, Stocker S, Bise K, Reulen HJ, Stummer W. Photoirradiation therapy of experimental malignant glioma with
5-aminolevulinic acid. J Neurosurg 2002;97:970-6.
46. Madsen SJ, Angell-Petersen E, Spetalen S, Carper SW, Ziegler SA, Hirschberg H. Photodynamic therapy of newly implanted glioma
cells in the rat brain. Lasers Surg Med 2006;38:540-8.
47. Gollnick SO, Vaughan L, Henderson BW. Generation of effective antitumor vaccines using photodynamic therapy. Cancer Res
2002;62:1604-8.
48. Korbelik M, Sun J. Photodynamic therapy-generated vaccine for cancer therapy. Cancer Immunol Immunother 2006;55:900-9.
49. Korbelik M, Stott B, Sun J. Photodynamic therapy-generated vaccines: relevance of tumour cell death expression. Br J Cancer
2007;97:1381-7.
50. Etminan N, Peters C, Lakbir D, Bünemann E, Börger V, Sabel MC, Hänggi D, Steiger HJ, Stummer W, Sorg RV. Heat-shock protein
70-dependent dendritic cell activation by 5-aminolevulinic acid-mediated photodynamic treatment of human glioblastoma spheroids in
vitro. Br J Cancer 2011;105:961-9.
51. Shixiang Y, Xi S, Junliang L, Shanyi Z, Xingke X, Meiguang Z, Kai W, Fangcheng L. Antitumor efficacy of a photodynamic therapy-
generated dendritic cell glioma vaccine. Med Oncol 2011;28 Suppl 1:S453-61.
52. Ullrich E, Bonmort M, Mignot G, Kroemer G, Zitvogel L. Tumor stress, cell death and the ensuing immune response. Cell Death Differ
2008;15:21-8.
53. Ritz R, Roser F, Radomski N, Strauss WS, Tatagiba M, Gharabaghi A. Subcellular colocalization of hypericin with respect to
endoplasmic reticulum and Golgi apparatus in glioblastoma cells. Anticancer Res 2008;28:2033-8.
54. Garg AD, Krysko DV, Vandenabeele P, Agostinis P. Hypericin-based photodynamic therapy induces surface exposure of damage-
associated molecular patterns like HSP70 and calreticulin. Cancer Immunol Immunother 2012;61:215-21.
55. Zheng Y, Yin G, Le V, Zhang A, Chen S, Liang X, Liu J. Photodynamic-therapy activates immune response by disrupting immunity
homeostasis of tumor cells, which generates vaccine for cancer therapy. Int J Biol Sci 2016;12:120-32.
56. Garg AD, Krysko DV, Verfaillie T, Kaczmarek A, Ferreira GB, Marysael T, Rubio N, Firczuk M, Mathieu C, Roebroek AJ, Annaert W,
Golab J, de Witte P, Vandenabeele P, Agostinis P. A novel pathway combining calreticulin exposure and ATP secretion in immunogenic
cancer cell death. EMBO J 2012;31:1062-79.
57. Adkins I, Fucikova J, Garg AD, Agostinis P, Špíšek R. Physical modalities inducing immunogenic tumor cell death for cancer
immunotherapy. Oncoimmunology 2015;3:e968434.
58. Garg AD, Vandenberk L, Koks C, Verschuere T, Boon L, Van Gool SW, Agostinis P. Dendritic cell vaccines based on immunogenic cell
death elicit danger signals and T cell-driven rejection of high-grade glioma. Sci Transl Med 2016;8:328ra27.
59. Fridman WH, Pagès F, Sautès-Fridman C, Galon J. The immune contexture in human tumors: Impact on clinical outcome. Nat Rev
Cancer 2012;12:298-306.
60. Angell H, Galon J. From the immune contexture to the Immunoscore: the role of prognostic and predictive immune markers in cancer.
Curr Opin Immunol 2013;25:261-7.
61. Hume DA, Macrophages as APC and the dendritic cell myth. J Immunol 2008;181:5829-35.
62. Madsen SJ, Christie C, Huynh K, Peng Q, Uzal FA, Krasieva TB, Hirschberg H. Limiting glioma development by photodynamic
therapy-generated macrophage vaccine and allo-stimulation: an in vivo histological study in rats. J Biomed Opt 2018;23:1-7.
63. Stathopoulos A, Samuelson C, Milbouw G, Hermanne JP, Schijns VE, Chen TC. Therapeutic vaccination against malignant gliomas
based on allo-recognition and syngeneic tumor antigens: proof of principle in two strains of rat. Vaccine 2008;26:1764-72.